Risk of False-Positives With Alzheimer Disease Blood Test | ClinicLens

This Medical News article discusses a recent study in JAMA Neurology about the real-world use of the first approved plasma test for biomarkers of Alzheimer disease pathology.

Medical Literature · Updated 2026-08-02

← Back to articles

This standalone article is served from the ClinicLens content archive.

If the embedded page does not load in your browser, open it directly.